Beleodaq – Belinostat

Beleodaq (belinostat) is a cancer medication that interferes with the growth and spread of cancer cells in the body.

Beleodaq is used to treat peripheral T-cell lymphoma that has relapsed or has not responded to other treatments.

Beleodaq was approved by the US Food and Drug Administration (FDA) on an “accelerated” basis. In clinical studies, non-small cell lung tumors responded to this medicine. However, it has not been shown that belinostat can improve symptoms or lengthen survival time.

1499total visits,1visits today


There are no reviews yet.

Be the first to review “Beleodaq – Belinostat”